These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 2372906)

  • 21. Neutrophil depletion limited to reperfusion reduces myocardial infarct size after 90 minutes of ischemia. Evidence for neutrophil-mediated reperfusion injury.
    Litt MR; Jeremy RW; Weisman HF; Winkelstein JA; Becker LC
    Circulation; 1989 Dec; 80(6):1816-27. PubMed ID: 2598440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduction in reperfusion-induced myocardial necrosis in dogs by RheothRx injection (poloxamer 188 N.F.), a hemorheological agent that alters neutrophil function.
    Schaer GL; Hursey TL; Abrahams SL; Buddemeier K; Ennis B; Rodriguez ER; Hubbell JP; Moy J; Parrillo JE
    Circulation; 1994 Dec; 90(6):2964-75. PubMed ID: 7994844
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of a time window for therapy to reduce experimental canine myocardial injury: suppression of neutrophil activation during 72 hours of reperfusion.
    Simpson PJ; Fantone JC; Mickelson JK; Gallagher KP; Lucchesi BR
    Circ Res; 1988 Dec; 63(6):1070-9. PubMed ID: 2461814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protective effect of PEG-SOD against early coronary reperfusion injury assessed in reperfused and non-reperfused ischaemic areas of the same heart.
    Kanamasa K; Ishida N; Ishikawa K
    Acta Cardiol; 2001 Jun; 56(3):181-6. PubMed ID: 11471931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intracoronary adenosine administered after reperfusion limits vascular injury after prolonged ischemia in the canine model.
    Babbitt DG; Virmani R; Forman MB
    Circulation; 1989 Nov; 80(5):1388-99. PubMed ID: 2805274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduction of myocardial reperfusion injury by intravenous adenosine administered during the early reperfusion period.
    Pitarys CJ; Virmani R; Vildibill HD; Jackson EK; Forman MB
    Circulation; 1991 Jan; 83(1):237-47. PubMed ID: 1984882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduction in myocardial infarct size by the new potassium channel opener bimakalim.
    Auchampach JA; Gross GJ
    J Cardiovasc Pharmacol; 1994 Apr; 23(4):554-61. PubMed ID: 7516004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A3 adenosine receptor agonist IB-MECA reduces myocardial ischemia-reperfusion injury in dogs.
    Auchampach JA; Ge ZD; Wan TC; Moore J; Gross GJ
    Am J Physiol Heart Circ Physiol; 2003 Aug; 285(2):H607-13. PubMed ID: 12689858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of the KATP channel opener bimakalim on coronary blood flow, monophasic action potential duration, and infarct size in dogs.
    Yao Z; Gross GJ
    Circulation; 1994 Apr; 89(4):1769-75. PubMed ID: 8149542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Augmentation of endogenous adenosine attenuates myocardial 'stunning' independently of coronary flow or hemodynamic effects.
    Zughaib ME; Abd-Elfattah AS; Jeroudi MO; Sun JZ; Sekili S; Tang XL; Bolli R
    Circulation; 1993 Nov; 88(5 Pt 1):2359-69. PubMed ID: 8222129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Short-term synchronized retroperfusion before reperfusion reduces infarct size after prolonged ischemia in dogs.
    Wakida Y; Nordlander R; Kobayashi S; Kar S; Haendchen R; Corday E
    Circulation; 1993 Nov; 88(5 Pt 1):2370-80. PubMed ID: 8222130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The protective effects of cromakalim and pinacidil on reperfusion function and infarct size in isolated perfused rat hearts and anesthetized dogs.
    Grover GJ; Dzwonczyk S; Parham CS; Sleph PG
    Cardiovasc Drugs Ther; 1990 Apr; 4(2):465-74. PubMed ID: 2285630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of diltiazem on infarct size, reperfusion flow and flow reserve: the effect of timing of treatment.
    Grover GJ; Sleph PG; Parham CS
    J Pharmacol Exp Ther; 1988 Jul; 246(1):263-9. PubMed ID: 3392657
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The protective effect of interleukin-1 receptor antagonist on postischemic reperfused myocardium and its possible mechanism].
    Li YJ; Ding WH; Gao W; Huo Y; Hong T; Zhu RY; Ma DL
    Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):548-53. PubMed ID: 15144587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adenosine attenuates reperfusion-induced apoptotic cell death by modulating expression of Bcl-2 and Bax proteins.
    Zhao ZQ; Budde JM; Morris C; Wang NP; Velez DA; Muraki S; Guyton RA; Vinten-Johansen J
    J Mol Cell Cardiol; 2001 Jan; 33(1):57-68. PubMed ID: 11133223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preconditioning improves energy metabolism during reperfusion but does not attenuate myocardial stunning in porcine hearts.
    Miyamae M; Fujiwara H; Kida M; Yokota R; Tanaka M; Katsuragawa M; Hasegawa K; Ohura M; Koga K; Yabuuchi Y
    Circulation; 1993 Jul; 88(1):223-34. PubMed ID: 8319337
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short-term treatment with synchronized coronary venous retroperfusion before full reperfusion significantly reduces myocardial infarct size.
    Hatori N; Uriuda Y; Isozima K; Isono T; Okuda E; Hamada K; Nakahoshi I; Kurita A; Yoshizu H; Tanaka S
    Am Heart J; 1992 May; 123(5):1166-74. PubMed ID: 1575128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diltiazem at reperfusion reduces neutrophil accumulation and infarct size in dogs with ischaemic myocardium.
    Rousseau G; St-Jean G; Latour JG; Merhi Y; Nattel S; Waters D
    Cardiovasc Res; 1991 Apr; 25(4):319-29. PubMed ID: 1884391
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of acidotic blood reperfusion on reperfusion injury after coronary artery occlusion in the dog heart.
    Preckel B; Schlack W; Obal D; Barthel H; Ebel D; Grunert S; Thämer V
    J Cardiovasc Pharmacol; 1998 Feb; 31(2):179-86. PubMed ID: 9475258
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protection of ischemic/reperfused canine myocardium by CL18/6, a monoclonal antibody to adhesion molecule ICAM-1.
    Hartman JC; Anderson DC; Wiltse AL; Lane CL; Rosenbloom CL; Manning AM; Humphrey WR; Wall TM; Shebuski RJ
    Cardiovasc Res; 1995 Jul; 30(1):47-54. PubMed ID: 7553723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.